Fort Collins

Colorado Springs

DEA Contemplates Marijuana Rescheduling: Potential Impact on Legal Landscape

Marijuana’s status as a Schedule 1 drug at the federal level has long been a subject of debate and contention. While some states have moved towards legalization for both medical and recreational use, the federal government still classifies marijuana alongside substances like heroin. However, there may be a glimmer of hope for change on the horizon. The Drug Enforcement Administration (DEA) is currently evaluating the possibility of rescheduling marijuana, which could have far-reaching implications for the legal landscape surrounding this controversial plant.

The Current Classification

Under the existing federal classification system, Schedule 1 drugs are considered to have a high potential for abuse and no recognized medical use. This categorization has placed marijuana in the same legal category as some of the most potent and dangerous drugs, including heroin. Such a classification has long been a source of frustration for proponents of marijuana reform, particularly in states where its medicinal use is permitted.

DEA’s Reevaluation

Recently, the DEA sent a letter to lawmakers indicating its intention to investigate the issue of marijuana rescheduling and decide in the near future. This proactive approach is a notable departure from previous years when the DEA was criticized for dragging its feet on the matter. When Colorado requested consideration of marijuana rescheduling four years ago, it took the DEA nine months to respond, and the eventual response was negative.

Potential Impact

Rescheduling marijuana to a less severe category, such as Schedule 2 (alongside drugs like cocaine and opium) or even Schedule 3 (with substances like ketamine), could have significant ramifications. It would signal a recognition by the federal government that marijuana may have medical benefits and a lower potential for abuse than previously thought.

One of the most substantial outcomes of rescheduling would be the potential for increased medical marijuana research. Currently, the University of Mississippi is the sole institution authorized to grow marijuana for medical research in the United States. Rescheduling could open the door for additional universities and research institutions to contribute to our understanding of marijuana’s medical properties.

Furthermore, it could pave the way for more states to permit the use of marijuana for both medical and recreational purposes, allowing them to tap into the economic benefits, including tax revenue, associated with the legal cannabis industry.

Consulting a Drugged Driving Defense Attorney

While the potential for marijuana rescheduling is promising, it’s essential to remember that marijuana remains illegal at the federal level as of now. 

If you are facing drugged driving charges related to marijuana, prescription drugs, or other substances, seeking legal counsel from a drugged driving defense attorney is crucial. They can guide you in navigating the current legal landscape and help you work toward reducing or dismissing your penalties.


In conclusion, the DEA’s contemplation of marijuana rescheduling signifies a noteworthy advancement in the ongoing discussion surrounding cannabis legality. Stay informed about these changes, and if you find yourself in legal trouble related to drugged driving, consider consulting professionals like Thomas & Ahnell, LLC, who specialize in alcohol and drug-related driving offenses in Colorado.

Do you have further questions or concerns? Call us or contact the attorneys at Thomas & Ahnell, LLC, and we will be happy to help.

Skip to content